Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients

Transplant Proc. 2001 Nov-Dec;33(7-8):3102-3. doi: 10.1016/s0041-1345(01)02322-3.
No abstract available

MeSH terms

  • Administration, Oral
  • Cyclosporine / blood*
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Intestinal Absorption
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Transplantation, Homologous

Substances

  • Immunosuppressive Agents
  • Cyclosporine